Core Laboratories (CLB) Tops Q2 EPS by 4c

Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.22, $0.04 better than the analyst estimate of $0.18. Revenue for the quarter came in at $130.16 million versus the consensus estimate of $128 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• The Trade Desk (TTD) Reiterated at Market Perform by Citizens Amid Bad News
• Prologis makes unsolicited bid for SEGRO, valued at £12.6 billion